Assessment the effect of N Acetyl Cysteine on liver function test in patient with elective Coronary Artery Bypass Grafting with cardiopulmonary bypass
Journal of Cellular & Molecular Anesthesia,
Vol. 1 No. 3 (2016),
1 July 2016
,
Page 103-108
https://doi.org/10.22037/jcma.v1i3.11810
Abstract
Background: Liver ischemic insults are important sources of liver injuries leading to production of reactive oxygen species (ROS) and mediating liver cell injury. Glutathione mediated mechanisms are among the most important defense mechanisms of the liver; N-acetylcysteine (NAC) provides cysteine for glutathione defense mechanisms. Patients undergoing cardiac surgery are at increased risk of liver ischemia. This study was performed to assess the role of NAC in prevention of liver ischemia.Materials and Methods: In a double blind, randomized clinical trial, 90 patients entered the study in two groups (45 in each). Patients in the NAC group received 150 mg/Kg NAC after induction of anesthesia and the other group, the same volume of placebo. Serum levels of aspartate aminotransferase (AST), Alanine aminotransferase (ALT) and bilirubin were checked before and after the surgery. ANOVA was used for data analysis and p value less than 0.05 was considered statistically significant.Results: No difference between the two groups regarding basic variables; however, the postoperative values of AST and ALT were lower in the NAC group with statistically significant difference. Also, postoperative levels of total bilirubin were lower in the NAC group compared with the control group; a statistically significant difference.Conclusion: Patients undergoing CABG are advised to receive prophylactic 150 mg/Kg NAC to improve their postoperative levels of AST, ALT and bilirubin.Keywords: glutathione antioxidant mechanism, N-acetylcysteine; Aspartate aminotransferase (AST), Alanine aminotransferase (ALT), bilirubin, liver ischemia.
- N Acetyl Cysteine
- liver function test
- elective Coronary Artery Bypass Grafting
- cardiopulmonary bypass
How to Cite
References
de Andrade KQ, Moura FA, dos Santos JM, de Araujo OR, de Farias Santos JC, Goulart MO. Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine. International journal of molecular sciences. 2015;16(12):30269-308.
Sun Y, Pu LY, Lu L, Wang XH, Zhang F, Rao JH. N-acetylcysteine attenuates reactive-oxygen-species-mediated endoplasmic reticulum stress during liver ischemia-reperfusion injury. World journal of gastroenterology. 2014;20(41):15289-98.
Sener G, Tosun O, Sehirli AO, Kacmaz A, Arbak S, Ersoy Y, et al. Melatonin and N-acetylcysteine have beneficial effects during hepatic ischemia and reperfusion. Life sciences. 2003;72(24):2707-18.
Reyes RC, Cittolin-Santos GF, Kim JE, Won SJ, Brennan-Minnella AM, Katz M, et al. Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2016;13(1):217-25.
Kerksick C, Willoughby D. The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. Journal of the International Society of Sports Nutrition. 2005;2:38-44.
Kerksick C, Willoughby D. The Antioxidant Role of Glutathione and N-Acetyl-Cysteine Supplements and Exercise-Induced Oxidative Stress. Journal of the International Society of Sports Nutrition. 2005;2(2):1-7.
Matuszczak Y, Farid M, Jones J. Effect of n-acetylcysteine on glutathione oxidation and fatigue during handgrip exercise. Muscle Nerve. 2005;32.
Quadrilatero J, Hoffman-Goetz L. N-Acetyl-L-cysteine prevents exercise-induced intestinal lymphocyte apoptosis by maintaining intracellular glutathione levels and reducing mitochondrial membrane depolarization. Biochem Biophys Res Commun. 2004;319.
Quadrilatero J, Hoffman-Goetz L. N-Acetyl-L-Cysteine inhibits exercise-induced lymphocyte apoptotic protein alterations. Med Sci Sports Exerc. 2005;37.
Bavarsad Shahripour R, Harrigan MR, Alexandrov AV. N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities. Brain and behavior. 2014;4(2):108-22.
Forgiarini LF, Forgiarini LA, Jr., da Rosa DP, Silva MB, Mariano R, Paludo Ade O, et al. N-acetylcysteine administration confers lung protection in different phases of lung ischaemia-reperfusion injury. Interact Cardiovasc Thorac Surg. 2014;19(6):894-9.
Sanguinetti CM. N-acetylcysteine in COPD: why, how, and when? Multidisciplinary respiratory medicine. 2015;11:8.
Laubach VE, Sharma AK. Mechanisms of lung ischemia-reperfusion injury. Current opinion in organ transplantation. 2016;21(3):246-52.
Lancaster EM, Hiatt JR, Zarrinpar A. Acetaminophen hepatotoxicity: an updated review. Archives of toxicology. 2015;89(2):193-9.
Chayanupatkul M, Liangpunsakul S. Alcoholic hepatitis: a comprehensive review of pathogenesis and treatment. World journal of gastroenterology. 2014;20(20):6279-86.
Friede T, Kieser M. Sample size recalculation in internal pilot study designs: a review. Biometrical journal Biometrische Zeitschrift. 2006;48(4):537-55.
Schafer H, Timmesfeld N, Muller HH. An overview of statistical approaches for adaptive designs and design modifications. Biometrical journal Biometrische Zeitschrift. 2006;48(4):507-20.
Chughlay MF, Kramer N, Spearman CW, Werfalli M, Cohen K. N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review. Br J Clin Pharmacol. 2016;81(6):1021-9.
Chughlay MF, Kramer N, Werfalli M, Spearman W, Engel ME, Cohen K. N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review protocol. Systematic reviews. 2015;4:84.
Wang Q, Hou Y, Yi D, Wang L, Ding B, Chen X, et al. Protective effects of N-acetylcysteine on acetic acid-induced colitis in a porcine model. BMC gastroenterology. 2013;13:133.
Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Ciccolo A, Centorrino T, et al. Protective effects of n-acetylcysteine on lung injury and red blood cell modification induced by carrageenan in the rat. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2001;15(7):1187-200.
Guo H, Zhang J, Boudreau M, Meng J, Yin JJ, Liu J, et al. Intravenous administration of silver nanoparticles causes organ toxicity through intracellular ROS-related loss of inter-endothelial junction. Particle and fibre toxicology. 2016;13:21.
Sarges P, Steinberg JM, Lewis JH. Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature. Drug Saf. 2016.
Ghannoum M, Kazim S, Grunbaum AM, Villeneuve E, Gosselin S. Massive acetaminophen overdose: effect of hemodialysis on acetaminophen and acetylcysteine kinetics. Clinical toxicology (Philadelphia, Pa). 2016:1-4.
Cairney DG, Beckwith HK, Al-Hourani K, Eddleston M, Bateman DN, Dear JW. Plasma paracetamol concentration at hospital presentation has a dose-dependent relationship with liver injury despite prompt treatment with intravenous acetylcysteine. Clinical toxicology (Philadelphia, Pa). 2016;54(5):405-10.
Ibrahim ES, Sharawy A. Effectiveness of intravenous infusion of N-acetylcysteine in cirrhotic patients undergoing major abdominal surgeries. Saudi J Anaesth. 2015;9(3):272-8.
Aksit H, Bildik A. Determination of DNA damage in experimental liver intoxication and role of N-acetyl cysteine. Cell biochemistry and biophysics. 2014;70(2):1119-25.
Santiago FM, Olmedo C, Muffak-Granero K, Comino A, Villar JM, Garrote D, et al. Intraoperative pH values after N-acetylcysteine administration during liver transplantation. Transplantation proceedings. 2010;42(8):3164-6.
- Abstract Viewed: 1336 times
- PDF Downloaded: 519 times